- Home
- POWI vs CPRX Comparison
POWI vs CPRX Comparison
Compare POWI & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWI
- CPRX
- Stock Information
- Founded
- POWI 1988
- CPRX 2002
- Country
- POWI United States
- CPRX United States
- Employees
- POWI N/A
- CPRX N/A
- Industry
- POWI Semiconductors
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- POWI Technology
- CPRX Health Care
- Exchange
- POWI Nasdaq
- CPRX Nasdaq
- Market Cap
- POWI 2.6B
- CPRX 2.9B
- IPO Year
- POWI 1997
- CPRX 2006
- Fundamental
- Price
- POWI $54.48
- CPRX $23.54
- Analyst Decision
- POWI Buy
- CPRX Strong Buy
- Analyst Count
- POWI 6
- CPRX 7
- Target Price
- POWI $74.67
- CPRX $32.29
- AVG Volume (30 Days)
- POWI 551.2K
- CPRX 998.8K
- Earning Date
- POWI 05-12-2025
- CPRX 05-07-2025
- Dividend Yield
- POWI 1.53%
- CPRX N/A
- EPS Growth
- POWI N/A
- CPRX 178.13
- EPS
- POWI 0.64
- CPRX 1.57
- Revenue
- POWI $432,814,000.00
- CPRX $534,645,999.00
- Revenue This Year
- POWI $15.74
- CPRX $15.59
- Revenue Next Year
- POWI $17.08
- CPRX $8.90
- P/E Ratio
- POWI $85.70
- CPRX $14.91
- Revenue Growth
- POWI 0.67
- CPRX 29.97
- 52 Week Low
- POWI $40.78
- CPRX $14.47
- 52 Week High
- POWI $79.13
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- POWI 57.62
- CPRX 51.07
- Support Level
- POWI $48.80
- CPRX $23.28
- Resistance Level
- POWI $59.24
- CPRX $24.08
- Average True Range (ATR)
- POWI 1.88
- CPRX 0.88
- MACD
- POWI 0.82
- CPRX -0.04
- Stochastic Oscillator
- POWI 60.20
- CPRX 64.61
About POWI Power Integrations Inc.
Power Integrations Inc design, develop and market analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, and home-automation, or internet of things applications such as networked thermostats, power strips and security devices.. Geographically, the company generates maximum revenue from China and Hong Kong.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).